Search Results - "TORGUSON, Rebecca"

FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study by Waksman, Ron, MD, Legutko, Jacek, MD, Singh, Jasvindar, MD, Orlando, Quentin, DO, Marso, Steven, MD, Schloss, Timothy, MD, Tugaoen, John, MD, DeVries, James, MD, Palmer, Nicholas, MD, Haude, Michael, MD, Swymelar, Stacy, BS, Torguson, Rebecca, MPH

“…Objectives FIRST (Fractional Flow Reserve and Intravascular Ultrasound Relationship Study) aimed to determine the optimal minimum lumen area (MLA) by…”
Get full text

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold by Lipinski, Michael J., MD, PhD, Escarcega, Ricardo O., MD, Baker, Nevin C., DO, Benn, Hadiya A, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Waksman, Ron, MD

“…Abstract Objectives The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement…”
Get full text

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement by Barbash, Israel M., MD, Ben-Dor, Itsik, MD, Dvir, Danny, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MS, Torguson, Rebecca, MPH, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Patients undergoing transcatheter aortic valve replacement (TAVR) are at increased risk for acute kidney injury (AKI). The Valve Academic Research…”
Get full text

Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Goldstein, Steven A., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Weissman, Gaby, MD, Maluenda, Gabriel, MD, Gonzalez, Manuel A., MD, MPH, Wakabayashi, Kohei, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Objectives This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). Background The…”
Get full text

Choice of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Impacts Hemodynamics Differently According to Aortic Annular Size by Rogers, Toby, BM, BCh, PhD, Steinvil, Arie, MD, Gai, Jiaxiang, MSPH, Torguson, Rebecca, MPH, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita, MD, Lee, Sang Yeub, MD, Okubagzi, Petros, MD, Satler, Lowell F., MD, Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract We sought to determine whether balloon-expandable (BEV) and self-expanding (SEV) valves affect valve hemodynamics differently according to native…”
Get full text

Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System by Rogers, Toby, Alraies, M. Chadi, Torguson, Rebecca, Waksman, Ron

“…The sponsor presented data from a patient-level meta-analysis incorporating the results from 2 European randomized trials of the Sentinel device (CLEAN-TAVI5…”
Get full text

Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the AngelMed Guardian System by Rogers, Toby, Steinvil, Arie, Torguson, Rebecca, Waksman, Ron

Get full text

Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure by Negi, Smita I., MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Kiramijyan, Sarkis, MD, Koifman, Edward, MD, Chan, Rosanna, PhD, Randolph, Pamela, MD, Pichard, Augusto, MD, Satler, Lowell F., MD, Waksman, Ron, MD

“…Abstract Objectives The study sought to report safety and long-term clinical efficacy of intravascular brachytherapy (VBT) for recurrent drug-eluting stent…”
Get full text

Overview of the 2013 Food and Drug Administration Circulatory System Devices Panel Meeting on the MitraClip Delivery System by Minha, Sa’ar, Torguson, Rebecca, Waksman, Ron

Get full text

Impact of Pre-Procedural Serum Albumin Levels on Outcome of Patients Undergoing Transcatheter Aortic Valve Replacement by Koifman, Edward, MD, Magalhaes, Marco A., MD, Ben-Dor, Itsik, MD, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Fang, Chen, PhD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Negi, Smita I., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Corso, Paul J., MD, Shults, Christian, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Risk assessment for transcatheter aortic valve replacement (TAVR) patients is challenging, and surgical scores do not optimally correlate with outcome. The aim…”
Get full text

Drug-Coated Balloon for De Novo Coronary Artery Disease by Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Torguson, Rebecca, Weintraub, William S., Garcia-Garcia, Hector M., Waksman, Ron

“…Percutaneous coronary intervention with a drug-eluting stent is the most common mode of revascularization for coronary artery disease. However, restenosis…”
Get full text

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome by Waksman, Ron, MD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Suddath, William O., MD, Satler, Lowell F., MD, Martin, Brenda D., RN, Perlman, Timothy J., BSME, Maltais, Jo-Ann B., PhD, Weissman, Neil J., MD, Fitzgerald, Peter J., MD, Brewer, H. Bryan, MD

“…Objectives This study aimed to determine whether serial autologous infusions of selective high-density lipoprotein (HDL) delipidated plasma are feasible and…”
Get full text

Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System by Steinvil, Arie, MD, Rogers, Toby, MD, Torguson, Rebecca, MPH, Waksman, Ron, MD

“…Abstract Objectives This study aims to describe the discussions and recommendations made during the U.S. Food and Drug Administration (FDA) Circulatory System…”
Get full text

Impact of sex on long‐term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes by Roumeliotis, Anastasios, Claessen, Bimmer E., Sartori, Samantha, Cao, Davide, Qiu, Hanbo, Camaj, Anton, Nicolas, Johny, Chandiramani, Rishi, Goel, Ridhima, Chiarito, Mauro, Torguson, Rebecca, Sweeny, Joseph, Barman, Nitin, Krishnan, Prakash, Kini, Annapoorna, Sharma, Samin K, Dangas, George, Mehran, Roxana

“…Background Women with acute coronary syndrome (ACS) generally present with more comorbidities and experience worse clinical outcomes compared with males…”
Get full text

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy by McFadden, Eugène P, Stabile, Eugenio, Regar, Evelyn, Cheneau, Edouard, Ong, Andrew TL, Kinnaird, Timothy, Suddath, William O, Weissman, Neil J, Torguson, Rebecca, Kent, Kenneth M, Pichard, August D, Satler, Lowell F, Waksman, Ron, Serruys, Patrick W

“…Although the safety profiles of coronary stents eluting sirolimus or paclitaxel do not seem to differ from those of bare metal stents in the short-to-medium…”
Get full text

Comparison of Outcomes After Percutaneous Coronary Intervention Among Different Coronary Subsets (Stable and Unstable Angina Pectoris and ST-Segment and Non-ST-Segment Myocardial Infarction) by Loh, Joshua P., MBBS, Pendyala, Lakshmana K., MD, Kitabata, Hironori, MD, PhD, Torguson, Rebecca, MPH, Omar, Alfazir, MBChB, Minha, Sa'ar, MD, Chen, Fang, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Percutaneous coronary intervention in the setting of acute myocardial infarction is known to predict stent thrombosis (ST). This study aims to compare the ST…”
Get full text

Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database by Khalid, Nauman, Javed, Hasan, Rogers, Toby, Hashim, Hayder, Shlofmitz, Evan, Chen, Yuefeng, Khan, Jaffar M., Musallam, Anees, Torguson, Rebecca, Bernardo, Nelson L., Waksman, Ron

“…Objectives To assess the commonly reported complications and failure modes for FilterWire EZ Embolic Protection Devices (EPD) by analyzing the postmarketing…”
Get full text

Clinical Frailty as an Outcome Predictor After Transcatheter Aortic Valve Implantation by Rogers, Toby, Alraies, M. Chadi, Moussa Pacha, Homam, Bond, Elizabeth, Buchanan, Kyle D., Steinvil, Arie, Gai, Jiaxiang, Torguson, Rebecca, Ben-Dor, Itsik, Satler, Lowell F., Waksman, Ron

“…Society of Thoracic Surgeons (STS) score and frailty index are calculated routinely as part of transcatheter aortic valve implantation (TAVI) assessment to…”
Get full text

Prevalence and Effect of Myocardial Injury After Transcatheter Aortic Valve Replacement by Barbash, Israel M., MD, Dvir, Danny, MD, Ben-Dor, Itsik, MD, Badr, Salem, MD, Okubagzi, Petros, MD, Torguson, Rebecca, MPH, Corso, Paul J., MD, Xue, Zhenyi, MS, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The incidence and prognostic implication of myocardial injury after transcatheter aortic valve replacement (TAVR) have not been consistently studied. We aimed…”
Get full text

Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement by Steinvil, Arie, Buchanan, Kyle D., Kiramijyan, Sarkis, Bond, Elizabeth, Rogers, Toby, Koifman, Edward, Shults, Christian, Xu, Linzhi, Torguson, Rebecca, Okubagzi, Petros G., Pichard, Augusto D., Satler, Lowell F., Ben-Dor, Itsik, Waksman, Ron

“…The impact of frailty assessment on outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) remains unclear. Our aim was to evaluate the…”
Get full text